EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Activating AMPK improves pathological phenotypes due to mtDNA depletion

Gustavo Carvalho iD, Tran V H Nguyen, Bruno Repolês, Josefin M E Forslund, W M Ruchitha Rukmal Wijethunga, Farahnaz Ranjbarian, Isabela C Mendes, Choco Michael Gorospe, Namrata Chaudhari, Micol Falabella, Mara Doimo, Sjoerd Wanrooij und 3 weitere

The FEBS Journal · 2025

DOI: 10.1111/febs.70006 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FEBS Journal, 2025. Verfasst von Gustavo Carvalho und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Biochemistry and Biophysics, Umeå University, Umeå, Sweden. Hauptthemen laut MEDLINE: DNA, Mitochondrial, AMP-Activated Protein Kinases, Mitochondria, Thiophenes. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Åke Wiberg Stiftelse, Cancerfonden, Svenska Sällskapet för Medicinsk Forskning.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

AMP‐activated protein kinase (AMPK) is a master regulator of cellular energy homeostasis that also plays a role in preserving mitochondrial function and integrity. Upon a disturbance in the cellular energy state that increases AMP levels, AMPK activity promotes a switch from anabolic to catabolic metabolism to restore energy homeostasis. However, the level of severity of mitochondrial dysfunction required to trigger AMPK activation is currently unclear, as is whether stimulation of AMPK using specific agonists can improve the cellular phenotype following mitochondrial dysfunction. Using a cellular model of mitochondrial disease characterized by progressive mitochondrial DNA (mtDNA) depletion and deteriorating mitochondrial metabolism, we show that mitochondria‐associated AMPK becomes activated early in the course of the advancing mitochondrial dysfunction, before any quantifiable decrease in the ATP/(AMP + ADP) ratio or respiratory chain activity. Moreover, stimulation of AMPK activity using the specific small‐molecule agonist A‐769662 alleviated the mitochondrial phenotypes caused by the mtDNA depletion and restored normal mitochondrial membrane potential. Notably, the agonist treatment was able to partially restore mtDNA levels in cells with severe mtDNA depletion, while it had no impact on mtDNA levels of control cells. The beneficial impact of the agonist on mitochondrial membrane potential was also observed in cells from patients suffering from mtDNA depletion. These findings improve our understanding of the effects of specific small‐molecule activators of AMPK on mitochondrial and cellular function and suggest a potential application for these compounds in disease states involving mtDNA depletion.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DNA, MitochondrialAMP-Activated Protein KinasesMitochondriaThiophenesMitochondrial DiseasesHumansMembrane Potential, MitochondrialPhenotypePyronesEnzyme ActivationAdenosine TriphosphateBiphenyl Compounds

Stichwörter der Autor:innen

AMPKAMP‐activated protein kinasemitochondrial DNA depletionpolymerase ɣ

Substanzen

DNA, MitochondrialAMP-Activated Protein KinasesThiophenes4-hydroxy-3-(4-(2-hydroxyphenyl)phenyl)-6-oxo-7H-thieno(2,3-b)pyridine-5-carbonitrilePyronesAdenosine TriphosphateBiphenyl Compounds

Autor:innen und Institutionen

  • Department of Medical Biochemistry and Biophysics, Umeå University, Umeå, Sweden.
  • Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London, UK.
  • Clinical Genetics Unit, Department of Women and Children's Health, Padua University, Padua, Italy.
  • NHS Highly Specialised Service for Rare Mitochondrial Disorders, Queen Square Centre for Neuromuscular Diseases, The National Hospital for Neurology and Neurosurgery, London, UK.

ORCID-Profile: Gustavo Carvalho, Paulina H Wanrooij

Förderung

  • Åke Wiberg Stiftelse
  • Cancerfonden
  • Svenska Sällskapet för Medicinsk Forskning
  • Vetenskapsrådet
  • Knut och Alice Wallenbergs Stiftelse
  • Medical Research Council

Zitieren

APA

Carvalho, G., Nguyen, T. V. H., Repolês, B., Forslund, J. M. E., Wijethunga, W. M. R. R., Ranjbarian, F., Mendes, I. C., Gorospe, C. M., Chaudhari, N., Falabella, M., Doimo, M., Wanrooij, S., Pitceathly, R. D. S., Hofer, A., & Wanrooij, P. H. (2025). Activating AMPK improves pathological phenotypes due to mtDNA depletion. The FEBS Journal. https://doi.org/10.1111/febs.70006

Vancouver

Carvalho G, Nguyen TVH, Repolês B, Forslund JME, Wijethunga WMRR, Ranjbarian F, et al. Activating AMPK improves pathological phenotypes due to mtDNA depletion. The FEBS Journal. 2025. doi:10.1111/febs.70006

BibTeX
@article{Carvalho2025,
  author = {Carvalho, Gustavo and Nguyen, Tran V H and Repolês, Bruno and Forslund, Josefin M E and Wijethunga, W M Ruchitha Rukmal and Ranjbarian, Farahnaz and Mendes, Isabela C and Gorospe, Choco Michael and Chaudhari, Namrata and Falabella, Micol and Doimo, Mara and Wanrooij, Sjoerd and Pitceathly, Robert D S and Hofer, Anders and Wanrooij, Paulina H},
  title = {Activating AMPK improves pathological phenotypes due to mtDNA depletion},
  journal = {The FEBS Journal},
  year = {2025},
  doi = {10.1111/febs.70006}
}
Kostenlos starten →